A 54-year-old woman comes to the physician with abdominal distention and mild diffuse abdominal discomfort. She has not had nausea, vomiting, fever, or chills. She was diagnosed with alcoholic liver cirrhosis 2 years ago. Examination shows a protruding, distended abdomen that is dull to percussion with a positive fluid wave. Ultrasonography shows mild to moderate ascites. Appropriate treatment of the patient's condition is started. Four days later, the patient experiences palpitations and chest pain at home. She is brought to the emergency department, where her temperature is 37.3°C (99.1°F), pulse is 182/min, respirations are 18/min, and blood pressure is 82/50 mm Hg. An ECG shows ventricular tachycardia. Initial laboratory studies show:
Serum
Na+ 131 mEq/L
K+ 2.9 mEq/L
Cl- 92 mEq/L
Bicarbonate 34 mEq/L
Urea nitrogen 42 mg/dL
Creatinine 4.8 mg/dL
Glucose 90 mg/dL
Ca2+ 8.1 mg/dL
Mg2+ 1.5 mg/dL
Phosphate 4.7 mg/dL
Arterial Blood Gas
pH 7.52
pCO2 45 mm Hg
pO2 90.2 mm Hg
She is successfully cardioverted to normal sinus rhythm. Which of the following treatments is most likely responsible for this patient's presentation?
Q142
A 28-year-old man is brought to the emergency department after he was found half dressed and incoherent in the middle of the road. In the emergency department he states that he has not slept for 36 hours and that he has incredible ideas that will make him a billionaire within a few months. He also states that secret agents from Russia are pursuing him and that he heard one of them speaking through the hospital intercom. His past medical history is significant only for a broken arm at age 13. On presentation, his temperature is 102.2°F (39°C), blood pressure is 139/88 mmHg, pulse is 112/min, and respirations are 17/min. Physical exam reveals pupillary dilation and psychomotor agitation. Which of the following mechanisms is most likely responsible for this patient's symptoms?
Q143
A 59-year-old woman comes to the physician because of left leg swelling that started after a transcontinental flight. A duplex ultrasound of the left leg shows a noncompressible popliteal vein. A drug is prescribed that inhibits the coagulation cascade. Two weeks later, laboratory studies show:
Platelet count 210,000/mm3
Partial thromboplastin time 28 seconds (normal: 25-35)
Prothrombin time 12 seconds (normal: 11-13)
Thrombin time 15 seconds (control: 15 seconds)
Which of the following drugs was most likely prescribed?
Q144
A 32-year-old woman comes to the physician because of a 3-month history of irregular menses, milky discharge from her nipples, fatigue, and weight gain. Menses occur at irregular 25–40-day intervals and last 1–2 days with minimal flow. 5 months ago, she was started on clozapine for treatment of schizophrenia. She has hypothyroidism but has not been taking levothyroxine over the past 6 months. Visual field examination show no abnormalities. Her serum thyroid-stimulating hormone is 17.0 μU/mL and serum prolactin is 85 ng/mL. Which of the following is the most likely explanation for the nipple discharge in this patient?
Q145
A 68-year-old man comes to the physician because of a 6-week history of episodic tremors, headaches, and sweating. During this time, he has gained 2.5-kg (5 lb 8 oz). Two months ago, he was diagnosed with type 2 diabetes mellitus and treatment with an oral antidiabetic drug was initiated. The beneficial effect of the drug that was prescribed for this patient is most likely due to inhibition of which of the following?
Q146
A 46-year-old premenopausal woman undergoes lumpectomy after a diagnosis of invasive ductal carcinoma of the breast is made. Pathologic examination of the surgical specimen shows that the breast cancer cells stain positive for estrogen receptor and progesterone receptor, and negative for human epidermal growth factor receptor 2. Which of the following characteristics applies to the most appropriate pharmacotherapy for this patient's condition?
Q147
A 64-year-old woman is brought to the emergency department because of a 1-week history of progressive shortness of breath, lower extremity edema, and a 4-kg (9-lb) weight gain. She has ischemic cardiomyopathy and rheumatoid arthritis. Her respirations are 27/min. Examination shows pitting edema of the lower extremities and crackles over both lower lung fields. Therapy is initiated with intravenous furosemide. After 2 hours, urine output is minimal. Concomitant treatment with which of the following drugs is most likely to have contributed to treatment failure?
Q148
A 62-year-old man presents to his physician complaining of difficulty maintaining an erection over the past month. Otherwise he feels well. He has a history of hypertension and congestive heart failure. His current medications include metoprolol, amlodipine, furosemide, losartan, and aspirin. Three months ago, lisinopril was switched to losartan due to periodic cough. Two months ago, metoprolol and furosemide were added for better control of hypertension and edema, and the dose of amlodipine was reduced. He does not smoke. At the clinic, his blood pressure is 125/70 mm Hg, pulse is 58/min, and respirations are 14/min. Physical examination reveals clear lung sounds, a previously diagnosed systolic murmur, and mild pitting edema on the dorsum of both feet. Which of the following is the most appropriate modification in this patient’s medication?
Q149
A 75-year-old man presents with a tremor in his legs and arms. He says he has had the tremor for ‘many years’, but it has worsened in the last year. The tremor is more prominent at rest and nearly disappears on movement. He also says his family has mentioned that his movements have been slower, and he does feel like he has problem initiating movements. There is no significant past medical history. He says he often drinks wine, but this does not affect his tremors. The patient is afebrile and vital signs are within normal limits. On physical examination, the patient is hunched over and his face is expressionless throughout the examination. There is a ‘pill-rolling’ resting tremor that is accentuated when the patient is asked to clench the contralateral hand and alleviated by finger-nose testing. The patient is unable to play an imaginary piano with his fingers. There is the increased tone in the arm muscles bilaterally and resistance to passive movement at the elbow, knee, and hip joints is noted. When asked to walk across the room, the patient has difficulty taking the first step, has a stooped posture, and takes short rapid shuffling steps. Which of the following drugs would be the most effective treatment for this patient’s condition?
Q150
A 31-year-old woman comes to the physician because of headaches and nausea for 2 weeks. The headaches are worse on awakening and she describes them as 7 out of 10 in intensity. During this period, she has noticed brief episodes of visual loss in both eyes lasting several seconds, especially when she suddenly stands up or bends over. She is 165 cm (5 ft 5 in) tall and weighs 98 kg (216 lb); BMI is 36 kg/m2. Vital signs are within normal limits. Examination shows a visual acuity of 20/20 in both eyes with mild peripheral vision loss. Fundoscopic examination shows bilateral optic disc swelling. An MRI of the brain shows no abnormalities. A lumbar puncture is performed; opening pressure is 310 mm H2O. Cerebrospinal fluid analysis shows a leukocyte count of 4/mm3 (75% lymphocytes), a protein concentration of 35 mg/dL, and a glucose concentration of 45 mg/dL. Which of the following is the most appropriate next step in management?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 141: A 54-year-old woman comes to the physician with abdominal distention and mild diffuse abdominal discomfort. She has not had nausea, vomiting, fever, or chills. She was diagnosed with alcoholic liver cirrhosis 2 years ago. Examination shows a protruding, distended abdomen that is dull to percussion with a positive fluid wave. Ultrasonography shows mild to moderate ascites. Appropriate treatment of the patient's condition is started. Four days later, the patient experiences palpitations and chest pain at home. She is brought to the emergency department, where her temperature is 37.3°C (99.1°F), pulse is 182/min, respirations are 18/min, and blood pressure is 82/50 mm Hg. An ECG shows ventricular tachycardia. Initial laboratory studies show:
Serum
Na+ 131 mEq/L
K+ 2.9 mEq/L
Cl- 92 mEq/L
Bicarbonate 34 mEq/L
Urea nitrogen 42 mg/dL
Creatinine 4.8 mg/dL
Glucose 90 mg/dL
Ca2+ 8.1 mg/dL
Mg2+ 1.5 mg/dL
Phosphate 4.7 mg/dL
Arterial Blood Gas
pH 7.52
pCO2 45 mm Hg
pO2 90.2 mm Hg
She is successfully cardioverted to normal sinus rhythm. Which of the following treatments is most likely responsible for this patient's presentation?
A. Lisinopril
B. Acetazolamide
C. Mannitol
D. Furosemide (Correct Answer)
E. Hydrochlorothiazide
Explanation: ***Furosemide***
- The patient's **hypokalemia (2.9 mEq/L)**, **hypomagnesemia (1.5 mg/dL)**, and **metabolic alkalosis (pH 7.52, bicarbonate 34 mEq/L)** are characteristic side effects of **loop diuretics** like furosemide.
- These electrolyte imbalances, particularly **hypokalemia** and **hypomagnesemia**, can predispose to serious cardiac arrhythmias such as **ventricular tachycardia**, which the patient experienced.
- Loop diuretics are commonly used in combination with spironolactone for management of cirrhotic ascites.
*Lisinopril*
- Lisinopril is an **ACE inhibitor** and would typically cause **hyperkalemia**, not hypokalemia, due to its effect on aldosterone.
- It works by vasodilation and could potentially worsen hypotension, but it doesn't explain the patient's specific electrolyte disturbances or arrhythmia profile.
*Acetazolamide*
- Acetazolamide is a **carbonic anhydrase inhibitor** that can cause **metabolic acidosis** and hypokalemia but would not lead to the metabolic alkalosis observed here.
- It increases bicarbonate excretion, which is the opposite of this patient's acid-base status.
*Mannitol*
- Mannitol is an **osmotic diuretic** primarily used for cerebral edema or acute glaucoma.
- Its main effects relate to fluid shifts, and while it could cause electrolyte disturbances, it's not typically associated with this specific constellation of hypokalemia, hypomagnesemia, and metabolic alkalosis.
*Hydrochlorothiazide*
- Hydrochlorothiazide is a **thiazide diuretic** that can cause hypokalemia, hypomagnesemia, and metabolic alkalosis, similar to loop diuretics.
- However, **thiazides are not used for cirrhotic ascites** because they are ineffective in treating significant fluid overload and can worsen complications of cirrhosis. The standard treatment is spironolactone (aldosterone antagonist) with or without a loop diuretic like furosemide for refractory cases.
Question 142: A 28-year-old man is brought to the emergency department after he was found half dressed and incoherent in the middle of the road. In the emergency department he states that he has not slept for 36 hours and that he has incredible ideas that will make him a billionaire within a few months. He also states that secret agents from Russia are pursuing him and that he heard one of them speaking through the hospital intercom. His past medical history is significant only for a broken arm at age 13. On presentation, his temperature is 102.2°F (39°C), blood pressure is 139/88 mmHg, pulse is 112/min, and respirations are 17/min. Physical exam reveals pupillary dilation and psychomotor agitation. Which of the following mechanisms is most likely responsible for this patient's symptoms?
A. N-methyl-D-aspartate receptor antagonist
B. Gamma-aminobutyric acid receptor agonist
C. Increased biogenic amine release (Correct Answer)
D. 5-HT receptor agonist
E. Opioid receptor agonist
Explanation: ***Increased biogenic amine release***
- The patient exhibits a classic constellation of symptoms consistent with **stimulant intoxication**, including **psychomotor agitation**, **pupillary dilation**, **tachycardia**, **hyperthermia**, **insomnia**, **grandiosity**, and **paranoia**.
- Stimulants like **amphetamines** and **cocaine** primarily exert their effects by increasing the release and inhibiting the reuptake of **biogenic amines** (dopamine, norepinephrine, serotonin) in the brain, leading to an exaggerated sympathetic response and altered mental status.
*N-methyl-D-aspartate receptor antagonist*
- **NMDA receptor antagonists** (e.g., phencyclidine - PCP, ketamine) are associated with dissociative symptoms, nystagmus, and sometimes aggression, but generally do not present with the prominent **hyperthermia** and grandiosity seen here.
- While they can cause psychotic symptoms, the specific combination of signs points more strongly to **stimulant intoxication**.
*Gamma-aminobutyric acid receptor agonist*
- **GABA receptor agonists** (e.g., benzodiazepines, barbiturates) cause **CNS depression**, sedation, respiratory depression, and ataxia.
- These effects are contrary to the patient's presentation of **agitation**, **increased heart rate**, and **hyperthermia**.
*5-HT receptor agonist*
- While drugs like **LSD** and **MDMA** (ecstasy) act as 5-HT receptor agonists and can cause hallucinations and altered perception, the prominent **paranoia**, **grandiosity**, and **significant hyperthermia** in this scenario are more characteristic of stimulant toxicity, which involves a broader increase in biogenic amine release beyond just serotonin.
- MDMA, in particular, can cause hyperthermia, but the full clinical picture is more suggestive of traditional stimulants.
*Opioid receptor agonist*
- **Opioid receptor agonists** (e.g., heroin, morphine) typically cause **CNS depression**, **miosis** (pinpoint pupils), respiratory depression, and sedation.
- These effects are the **opposite** of the patient's symptoms of pupillary dilation, agitation, and hyperthermia.
Question 143: A 59-year-old woman comes to the physician because of left leg swelling that started after a transcontinental flight. A duplex ultrasound of the left leg shows a noncompressible popliteal vein. A drug is prescribed that inhibits the coagulation cascade. Two weeks later, laboratory studies show:
Platelet count 210,000/mm3
Partial thromboplastin time 28 seconds (normal: 25-35)
Prothrombin time 12 seconds (normal: 11-13)
Thrombin time 15 seconds (control: 15 seconds)
Which of the following drugs was most likely prescribed?
A. Unfractionated heparin
B. Apixaban
C. Aspirin
D. Warfarin
E. Low molecular weight heparin (Correct Answer)
Explanation: ***Low molecular weight heparin***
- **LMWH (e.g., enoxaparin) is the first-line treatment for acute DVT** in ambulatory patients and is the most likely drug prescribed in this outpatient scenario
- LMWH enhances **antithrombin activity primarily against Factor Xa** (more than Factor IIa/thrombin), which is why it has **minimal effect on routine coagulation tests** (PT, PTT, TT)
- **Monitoring of LMWH is done via anti-Xa levels**, not PTT, PT, or TT, explaining why all these values remain normal two weeks after initiation
- The normal coagulation studies are **expected and consistent** with therapeutic LMWH use
*Unfractionated heparin*
- Unfractionated heparin (UFH) acts by enhancing **antithrombin activity against both Factor Xa and Factor IIa (thrombin)**, which significantly **prolongs PTT** (typically 1.5-2x control when therapeutic)
- UFH requires **IV administration and hospital monitoring**, making it unlikely for this ambulatory post-flight DVT patient
- If the patient were currently on UFH, the **PTT would be prolonged** (not normal as shown); if discontinued, this wouldn't be "the drug prescribed" for ongoing DVT treatment
*Apixaban*
- Apixaban is a **direct Factor Xa inhibitor** that would cause **mild prolongation of PT** and possibly PTT at therapeutic levels
- While it's a reasonable outpatient DVT treatment, the completely normal PT argues against current apixaban use
- Apixaban doesn't require routine monitoring, but when measured, coagulation times would typically show some abnormality
*Warfarin*
- Warfarin is a **vitamin K antagonist** that inhibits synthesis of factors II, VII, IX, and X, causing **significant PT/INR prolongation** (target INR 2-3 for DVT)
- The **normal PT (12 seconds) excludes warfarin** as the current medication
- Warfarin requires regular INR monitoring and would not show normal values at therapeutic doses
*Aspirin*
- Aspirin is an **antiplatelet agent** (COX-1 inhibitor) that affects platelet aggregation, **not the coagulation cascade**
- It has **no effect on PT, PTT, or TT** and is **inadequate monotherapy for DVT treatment**
- While it may have a role in extended VTE prevention, it would not be the primary drug prescribed for acute DVT
Question 144: A 32-year-old woman comes to the physician because of a 3-month history of irregular menses, milky discharge from her nipples, fatigue, and weight gain. Menses occur at irregular 25–40-day intervals and last 1–2 days with minimal flow. 5 months ago, she was started on clozapine for treatment of schizophrenia. She has hypothyroidism but has not been taking levothyroxine over the past 6 months. Visual field examination show no abnormalities. Her serum thyroid-stimulating hormone is 17.0 μU/mL and serum prolactin is 85 ng/mL. Which of the following is the most likely explanation for the nipple discharge in this patient?
A. Prolactinoma
B. Thyrotropic pituitary adenoma
C. Ectopic prolactin production
D. Hypothyroidism (Correct Answer)
E. Adverse effect of medication
Explanation: ***Hypothyroidism***
- **Primary hypothyroidism** is the most likely cause of this patient's galactorrhea given her significantly elevated TSH (17.0 μU/mL) and 6-month non-compliance with levothyroxine.
- In hypothyroidism, elevated **TRH (thyrotropin-releasing hormone)** stimulates both TSH and **prolactin release** from the anterior pituitary, commonly causing prolactin levels in the 50-100 ng/mL range.
- The patient's prolactin level of **85 ng/mL is entirely consistent** with hypothyroidism-induced hyperprolactinemia.
- Hypothyroidism also explains her other symptoms: **fatigue, weight gain, and menstrual irregularities**.
*Adverse effect of medication*
- While some antipsychotics cause significant hyperprolactinemia, **clozapine is notably prolactin-sparing** due to its weak D2 receptor antagonism and rapid dissociation from D2 receptors.
- Clozapine is one of the **atypical antipsychotics with the lowest risk** of causing elevated prolactin levels.
- Antipsychotics that commonly cause hyperprolactinemia include **risperidone, paliperidone, amisulpride, and typical antipsychotics** (e.g., haloperidol), but not clozapine.
- Given the patient's untreated hypothyroidism, this is the less likely cause.
*Prolactinoma*
- A prolactinoma would typically present with **significantly higher prolactin levels** (usually >200 ng/mL for macroadenomas, though microprolactinomas may have levels 100-200 ng/mL).
- The patient's prolactin of 85 ng/mL is **more consistent with secondary causes** like hypothyroidism or medications.
- The absence of **visual field defects** makes a large macroadenoma less likely.
*Thyrotropic pituitary adenoma*
- A thyrotropic (TSH-secreting) pituitary adenoma causes **secondary hyperthyroidism** with elevated TSH and elevated thyroid hormones, not hypothyroidism.
- This patient has **primary hypothyroidism** (elevated TSH with presumably low T4), which is the opposite presentation.
- TSH-secreting adenomas are extremely rare (<1% of pituitary adenomas).
*Ectopic prolactin production*
- **Ectopic prolactin production** by non-pituitary tumors is exceedingly rare and usually associated with very high prolactin levels.
- There are no clinical features suggesting an ectopic source or malignancy.
- The patient's presentation is fully explained by her untreated hypothyroidism.
Question 145: A 68-year-old man comes to the physician because of a 6-week history of episodic tremors, headaches, and sweating. During this time, he has gained 2.5-kg (5 lb 8 oz). Two months ago, he was diagnosed with type 2 diabetes mellitus and treatment with an oral antidiabetic drug was initiated. The beneficial effect of the drug that was prescribed for this patient is most likely due to inhibition of which of the following?
A. ATP-sensitive potassium channels (Correct Answer)
B. Glycerophosphate dehydrogenase
C. Sodium-glucose cotransporter-2
D. Dipeptidyl peptidase-4
E. Brush-border α-glucosidase
Explanation: ***ATP-sensitive potassium channels***
- The patient's symptoms of episodic tremors, headaches, sweating, and weight gain, along with a recent diagnosis of type 2 diabetes treated with an oral antidiabetic drug, suggest **hypoglycemia** as a side effect.
- Sulfonylureas, a common class of oral antidiabetic drugs, exert their effect by **inhibiting ATP-sensitive potassium channels** on pancreatic beta cells, leading to insulin release and potentially hypoglycemia.
*Glycerophosphate dehydrogenase*
- This enzyme is involved in **glycerol metabolism** and is not a primary target for oral antidiabetic drugs that cause hypoglycemia.
- Its inhibition would not directly lead to increased insulin secretion or the described pattern of symptoms.
*Sodium-glucose cotransporter-2*
- **SGLT2 inhibitors** (e.g., canagliflozin) work by blocking glucose reabsorption in the kidneys, leading to glucose excretion in urine.
- While they can cause some weight loss, they are less likely to cause symptomatic hypoglycemia unless combined with other agents, and their mechanism does not involve ATP-sensitive potassium channels.
*Dipeptidyl peptidase-4*
- **DPP-4 inhibitors** (e.g., sitagliptin) prevent the breakdown of incretin hormones, thereby increasing insulin secretion in a glucose-dependent manner.
- These drugs generally have a **low risk of hypoglycemia** because their effect on insulin release diminishes as blood glucose normalizes.
*Brush-border α-glucosidase*
- **Alpha-glucosidase inhibitors** (e.g., acarbose) delay carbohydrate absorption in the gut.
- They primarily target **postprandial hyperglycemia** and, when used alone, cause very little risk of hypoglycemia because they do not directly stimulate insulin secretion.
Question 146: A 46-year-old premenopausal woman undergoes lumpectomy after a diagnosis of invasive ductal carcinoma of the breast is made. Pathologic examination of the surgical specimen shows that the breast cancer cells stain positive for estrogen receptor and progesterone receptor, and negative for human epidermal growth factor receptor 2. Which of the following characteristics applies to the most appropriate pharmacotherapy for this patient's condition?
A. Monoclonal antibody against tyrosine kinase receptor
B. Monoclonal antibody against vascular endothelial growth factor
C. Selective agonist at progesterone receptors in mammary tissue
D. Selective agonist at estrogen receptors in bone tissue
E. Selective antagonist at estrogen receptors in mammary tissue (Correct Answer)
Explanation: ***Selective antagonist at estrogen receptors in mammary tissue***
- The patient's tumor is **estrogen receptor (ER) positive** and **progesterone receptor (PR) positive**. This indicates a **hormone-sensitive cancer**, making endocrine therapy the most appropriate pharmacotherapy.
- A **selective antagonist at estrogen receptors** in mammary tissue, such as **tamoxifen** (a selective estrogen receptor modulator, SERM), is effective in blocking estrogen-mediated tumor growth in premenopausal patients.
*Monoclonal antibody against tyrosine kinase receptor*
- This therapy, typically targeting **HER2 (human epidermal growth factor receptor 2)**, would be appropriate if the tumor was **HER2-positive**.
- The patient's tumor is **HER2-negative**, meaning this type of targeted therapy would not be beneficial.
*Monoclonal antibody against vascular endothelial growth factor*
- This class of drugs, like **bevacizumab**, targets **angiogenesis** by inhibiting VEGF, which is crucial for tumor blood supply.
- While used in some cancers, it is not the primary or most appropriate pharmacotherapy based on the specific receptor status of this patient's breast cancer.
*Selective agonist at progesterone receptors in mammary tissue*
- An **agonist** at progesterone receptors would **promote growth** if the tumor is progesterone receptor-positive, which would be counterproductive for cancer treatment.
- The goal of endocrine therapy for PR-positive tumors is to inhibit the effects of progesterone.
*Selective agonist at estrogen receptors in bone tissue*
- An agonist at estrogen receptors in bone tissue would **mimic estrogen's effects**, which is undesirable given the estrogen-sensitive nature of the breast cancer.
- While some SERMs (like tamoxifen) can have agonist effects in bone (which can be beneficial for bone density), the primary therapeutic action for breast cancer is antagonism in mammary tissue.
Question 147: A 64-year-old woman is brought to the emergency department because of a 1-week history of progressive shortness of breath, lower extremity edema, and a 4-kg (9-lb) weight gain. She has ischemic cardiomyopathy and rheumatoid arthritis. Her respirations are 27/min. Examination shows pitting edema of the lower extremities and crackles over both lower lung fields. Therapy is initiated with intravenous furosemide. After 2 hours, urine output is minimal. Concomitant treatment with which of the following drugs is most likely to have contributed to treatment failure?
A. Sulfasalazine
B. Digoxin
C. Prednisone
D. Infliximab
E. Diclofenac (Correct Answer)
Explanation: ***Diclofenac***
- **NSAIDs** like diclofenac can cause **sodium and water retention** and reduce the effectiveness of loop diuretics like furosemide by inhibiting prostaglandin synthesis in the kidneys.
- This patient's symptoms of **heart failure exacerbation** (shortness of breath, edema, weight gain, crackles) and minimal urine output despite furosemide suggest drug-induced diuretic resistance.
*Sulfasalazine*
- This drug is used for **rheumatoid arthritis** and inflammatory bowel disease, but it does not typically interfere with diuretic action or cause fluid retention.
- Its mechanism involves anti-inflammatory properties, not directly affecting renal hemodynamics or diuretic efficacy.
*Digoxin*
- Digoxin is used to improve **cardiac contractility** and does not directly cause fluid retention or diminish the effects of loop diuretics.
- While it has a narrow therapeutic index, it does not antagonize furosemide's action.
*Prednisone*
- Prednisone is a **corticosteroid** that can cause **fluid retention** due to its mineralocorticoid effects, but it is not known to directly inhibit the action of loop diuretics to this extent.
- Its use in rheumatoid arthritis would primarily suppress inflammation, not directly cause diuretic resistance in acute heart failure.
*Infliximab*
- Infliximab is a **TNF-alpha inhibitor** used in rheumatoid arthritis; it can rarely exacerbate heart failure by its mechanism of action but does not directly interfere with the efficacy of loop diuretics.
- It does not cause fluid retention through renal mechanisms or reduce the renal response to furosemide.
Question 148: A 62-year-old man presents to his physician complaining of difficulty maintaining an erection over the past month. Otherwise he feels well. He has a history of hypertension and congestive heart failure. His current medications include metoprolol, amlodipine, furosemide, losartan, and aspirin. Three months ago, lisinopril was switched to losartan due to periodic cough. Two months ago, metoprolol and furosemide were added for better control of hypertension and edema, and the dose of amlodipine was reduced. He does not smoke. At the clinic, his blood pressure is 125/70 mm Hg, pulse is 58/min, and respirations are 14/min. Physical examination reveals clear lung sounds, a previously diagnosed systolic murmur, and mild pitting edema on the dorsum of both feet. Which of the following is the most appropriate modification in this patient’s medication?
A. Increasing the amlodipine dose
B. Discontinuing furosemide
C. Reducing the metoprolol dose (Correct Answer)
D. Adding indapamide
E. Switching losartan to lisinopril
Explanation: ***Reducing the metoprolol dose***
- The patient's **bradycardia** (pulse 58/min) and **erectile dysfunction (ED)** are common side effects of **beta-blockers** like metoprolol.
- Given his controlled blood pressure, reducing the metoprolol dose is the most appropriate step to mitigate these side effects while maintaining cardiovascular benefit.
*Increasing the amlodipine dose*
- Increasing amlodipine could worsen his **edema** and might lead to **hypotension**, especially with his current well-controlled blood pressure.
- Amlodipine is less likely to cause ED compared to metoprolol and is usually not the primary cause in this context.
*Discontinuing furosemide*
- Furosemide is crucial for managing his **congestive heart failure** and **edema**, which is still present (mild pitting edema).
- Discontinuing it could lead to worsening fluid overload and heart failure symptoms.
*Adding indapamide*
- Indapamide is a **thiazide-like diuretic** that could further lower blood pressure, but the patient's blood pressure is already well-controlled.
- Adding another diuretic is unlikely to address his ED and could lead to electrolyte imbalances or dehydration.
*Switching losartan to lisinopril*
- The patient was switched from lisinopril to losartan due to a **cough**, which is a known side effect of **ACE inhibitors**.
- Reintroducing lisinopril would likely cause the cough to return and does not address the current ED or bradycardia.
Question 149: A 75-year-old man presents with a tremor in his legs and arms. He says he has had the tremor for ‘many years’, but it has worsened in the last year. The tremor is more prominent at rest and nearly disappears on movement. He also says his family has mentioned that his movements have been slower, and he does feel like he has problem initiating movements. There is no significant past medical history. He says he often drinks wine, but this does not affect his tremors. The patient is afebrile and vital signs are within normal limits. On physical examination, the patient is hunched over and his face is expressionless throughout the examination. There is a ‘pill-rolling’ resting tremor that is accentuated when the patient is asked to clench the contralateral hand and alleviated by finger-nose testing. The patient is unable to play an imaginary piano with his fingers. There is the increased tone in the arm muscles bilaterally and resistance to passive movement at the elbow, knee, and hip joints is noted. When asked to walk across the room, the patient has difficulty taking the first step, has a stooped posture, and takes short rapid shuffling steps. Which of the following drugs would be the most effective treatment for this patient’s condition?
A. Bromocriptine
B. Entacapone
C. Benztropine
D. Selegiline
E. Levodopa/carbidopa (Correct Answer)
Explanation: **Levodopa/carbidopa**
- The patient's symptoms (resting tremor, bradykinesia, rigidity, postural instability, and shuffling gait) are classic for **Parkinson's disease**. **Levodopa/carbidopa** is the most effective treatment for the motor symptoms of Parkinson's disease, as levodopa is converted to dopamine in the brain, and carbidopa prevents its peripheral breakdown, allowing more to reach the brain.
- It significantly improves **bradykinesia and rigidity**, which are prominent features in this patient, and can also help with tremor and gait difficulties.
*Bromocriptine*
- Bromocriptine is a **dopamine agonist** that directly stimulates dopamine receptors. While it can also treat Parkinson's symptoms, it is generally less effective than levodopa/carbidopa, especially in later stages or for severe symptoms.
- It is more commonly used as an initial therapy in younger patients to delay levodopa use or as an adjunct therapy, but for a 75-year-old with advanced symptoms, levodopa/carbidopa is preferred.
*Entacapone*
- Entacapone is a **catechol-O-methyltransferase (COMT) inhibitor** that prolongs the action of levodopa by preventing its breakdown in the periphery.
- It is not used as a monotherapy but rather as an **adjunct to levodopa/carbidopa** in patients experiencing "wearing off" phenomena, where levodopa's effects diminish before the next dose.
*Benztropine*
- Benztropine is an **anticholinergic medication** used primarily to treat tremor and dystonia in Parkinson's disease.
- It is generally less effective for bradykinesia and rigidity and is often avoided in elderly patients due to potential side effects like confusion, hallucinations, and urinary retention.
*Selegiline*
- Selegiline is a **monoamine oxidase-B (MAO-B) inhibitor** that prevents the breakdown of dopamine in the brain.
- It is used in early Parkinson's disease or as an adjunct to levodopa/carbidopa to extend its effects; however, its symptomatic efficacy is modest compared to levodopa/carbidopa.
Question 150: A 31-year-old woman comes to the physician because of headaches and nausea for 2 weeks. The headaches are worse on awakening and she describes them as 7 out of 10 in intensity. During this period, she has noticed brief episodes of visual loss in both eyes lasting several seconds, especially when she suddenly stands up or bends over. She is 165 cm (5 ft 5 in) tall and weighs 98 kg (216 lb); BMI is 36 kg/m2. Vital signs are within normal limits. Examination shows a visual acuity of 20/20 in both eyes with mild peripheral vision loss. Fundoscopic examination shows bilateral optic disc swelling. An MRI of the brain shows no abnormalities. A lumbar puncture is performed; opening pressure is 310 mm H2O. Cerebrospinal fluid analysis shows a leukocyte count of 4/mm3 (75% lymphocytes), a protein concentration of 35 mg/dL, and a glucose concentration of 45 mg/dL. Which of the following is the most appropriate next step in management?
A. Prednisone therapy
B. Optic nerve sheath fenestration
C. Acetazolamide therapy (Correct Answer)
D. Furosemide therapy
E. Ventricular shunting
Explanation: ***Acetazolamide therapy***
- This patient presents with symptoms and signs consistent with **idiopathic intracranial hypertension (IIH)**: **headaches worse on awakening**, transient visual obscurations, **papilledema** on fundoscopic exam, elevated **BMI**, normal brain MRI, and **elevated CSF opening pressure** with normal CSF content.
- **Acetazolamide** is the first-line medical treatment for IIH, working as a **carbonic anhydrase inhibitor** to decrease CSF production and thus lower intracranial pressure.
*Prednisone therapy*
- **Prednisone** is a corticosteroid that can reduce inflammation and edema, but it is **not the first-line treatment** for IIH and its prolonged use carries significant side effects.
- While it may temporarily reduce intracranial pressure, it does not address the underlying pathophysiology of **CSF overproduction** or impaired absorption in IIH as effectively as acetazolamide.
*Optic nerve sheath fenestration*
- **Optic nerve sheath fenestration** is a surgical procedure considered for IIH patients with **progressive vision loss despite maximal medical therapy**, or those who cannot tolerate medical therapy.
- It is an **invasive procedure** and not the initial management step for this patient, who has only mild peripheral vision loss and has not yet attempted medical treatment.
*Furosemide therapy*
- **Furosemide** is a loop diuretic that primarily reduces systemic fluid volume and can sometimes be used as an **adjunct** in resistant cases or to potentiate acetazolamide's effect in IIH.
- However, it is **less effective than acetazolamide** in directly reducing CSF production and is not considered a first-line monotherapy for IIH.
*Ventricular shunting*
- **Ventricular shunting** (e.g., ventriculoperitoneal shunt) is a more invasive surgical option considered for severe, refractory cases of IIH, particularly those with **intractable headaches** or **severe, progressive vision loss** that has failed other treatments.
- Given that this patient has not yet received initial medical therapy, **ventricular shunting is premature** as a next step in management.